VALIANT LABORATORIES
|
VALIANT LABORATORIES Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | |
---|---|---|
Profit Before Tax | ₹-0.77 Cr | ₹38 Cr |
Adjustment | ₹2.04 Cr | ₹1.56 Cr |
Changes In working Capital | ₹-0.37 Cr | ₹25 Cr |
Cash Flow after changes in Working Capital | ₹0.90 Cr | ₹65 Cr |
Cash Flow from Operating Activities | ₹1.89 Cr | ₹56 Cr |
Cash Flow from Investing Activities | ₹-144 Cr | ₹-55 Cr |
Cash Flow from Financing Activities | ₹152 Cr | ₹-0.93 Cr |
Net Cash Inflow / Outflow | ₹10 Cr | ₹-0.05 Cr |
Opening Cash & Cash Equivalents | ₹1.26 Cr | ₹1.31 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - |
Effect of Foreign Exchange Fluctuations | - | - |
Closing Cash & Cash Equivalent | ₹12 Cr | ₹1.26 Cr |
Compare Cashflow Statement of peers of VALIANT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VALIANT LABORATORIES | ₹355.7 Cr | -3.1% | -11.1% | -47.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹411,306.0 Cr | -3.9% | 3% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹150,343.0 Cr | -5% | -1.1% | 71.6% | Stock Analytics | |
CIPLA | ₹117,323.0 Cr | -4.4% | 0.2% | -1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,619.0 Cr | -1.6% | 6.5% | 26.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,941.5 Cr | -2.4% | 2.4% | -5.4% | Stock Analytics |
VALIANT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VALIANT LABORATORIES | -3.1% |
-11.1% |
-47.1% |
SENSEX | -1.8% |
2.7% |
5% |
You may also like the below Video Courses